Search Orphan Drug Designations and Approvals
-
| Generic Name: | peptide conjugated phosphorodiamidate morpholino oligomer (PPMO) |
|---|---|
| Date Designated: | 11/12/2020 |
| Orphan Designation: | treatment of Duchenne muscular dystrophy |
| Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Sarepta Therapeutics, Inc. 215 First Street Cambridge, Massachusetts 02142 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







